Search

everythinglearnresearchcommunity

for

Search:↓

Some hair loss and prostate drugs might increase the risk of diabetes and heart disease.

Certain Dibenzo derivatives may help treat prostate cancer.

Three natural compounds from Ghanaian plants may help treat BPH and alopecia.

New compounds called benzoquinolinones may treat conditions linked to excess DHT.

Finasteride safely treats enlarged prostate and male-pattern baldness.

5-Alpha reductase inhibitors are safe long-term but may be outdated for preventing less significant prostate cancer.

New nonsteroidal molecules can potentially increase dihydrotestosterone in neurons by blocking certain enzymes, without affecting prostate and seminal vesicle weight.

Taking medication for hair loss might cause sexual problems.

Analog 23 is a promising compound for prostate cancer treatment.

Men on 5-alpha-reductase inhibitors might have worse COVID-19 outcomes.

Using 5-alpha-reductase inhibitors, drugs for prostate issues and hair loss, may lead to eye abnormalities in men.

Finasteride effectively inhibits the enzyme steroid 5 alpha-reductase II.

Finasteride, a drug, can block the seizure-preventing effects of a hormone called progesterone in mice.

5ARI treatment improves hair growth in older men with minimal side effects.

New pyrazole-based inhibitors show promise for treating metabolic diseases and other conditions.

Men over 66 taking medication for prostate enlargement have a higher risk of depression and self-harm, especially in the first 18 months of treatment.

Benzothiazepines like diltiazem reduce anxiety in mice by making neurosteroids.

Finasteride raises suicide-linked aggression and stops clozapine's positive effects in schizophrenia animals.

5α-reductase inhibitors help manage symptoms of benign prostatic hyperplasia and may also prevent prostate cancer and treat hair loss.

5-alpha-reductase inhibitors can effectively treat benign prostatic hyperplasia.

Inhibiting testosterone 5alpha-reductase may help treat benign prostatic hyperplasia.

Finasteride and dutasteride are equally effective and safe for treating benign prostatic hyperplasia.

Finasteride reduces opioid use and withdrawal symptoms in animals.

New treatments targeting androgen receptors show promise for drug-resistant prostate cancer.

Using 5-α-reductase inhibitors before treatment improves outcomes for patients with metastatic renal cell carcinoma.

5α‐reductase isozymes are crucial for prostate development and health, and targeting them can help prevent and treat prostate issues.

Anti-androgen drugs can help reduce OCD symptoms, but more large-scale trials are needed to confirm their effectiveness.

New compounds with carborane showed anti-androgen effects similar to flutamide.

5α-Reductase inhibitors, like finasteride, can cause serious, persistent side effects not always listed in official drug information.

AC-5216 reduces anxiety in mice through neurosteroids affecting GABAA receptors.